WHO ICTRP trial
Evaluation study on the effectiveness and safety of Lubiprostone combined with…
ChiCTR2500096667 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2500096667 |
|---|---|
| Public title | Evaluation study on the effectiveness and safety of Lubiprostone combined with magnesium sulfate in bowel preparation for elderly patients with constipation |
| Scientific title | Evaluation study on the effectiveness and safety of Lubiprostone combined with magnesium sulfate in bowel preparation for elderly patients with constipation |
| Primary sponsor | Shanghai Geriatric Medical Center |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Countries | China |
| Conditions | elderly constipation |
| Interventions | Experimental group:Lubiprostone;Control group:placebo |
| Registration date | Jan 27, 2025 |
| Target size | Experimental group:50;Control group:50 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: